1994
DOI: 10.1016/0016-5085(94)90017-5
|View full text |Cite
|
Sign up to set email alerts
|

Fibroblast growth factors modulate intestinal epithelial cell growth and migration

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4

Citation Types

3
155
1
7

Year Published

1995
1995
2011
2011

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 256 publications
(166 citation statements)
references
References 27 publications
3
155
1
7
Order By: Relevance
“…It has been shown that stromal fibroblasts supply many of the angiogenetic factors to the microenvironment of the healing wound and cancer (Fukumura et al, 1998). As expected from the findings of our cell proliferation assays using conditioned media, we identified upregulated secreted factors and cytokines that have been shown to promote cancer cell growth and survival including PDGF (Westermark and Heldin, 1991), TGFB2 (Derynck et al, 2001), FGF1 (Dignass et al, 1994), IGF binding proteins (Miyakoshi et al, 2001), MCP1 (Youngs et al, 1997), IL-6 (Conze et al, 2001), osteoprotegrin (Holen et al, 2002), ICAM1 (Gho et al, 2001), follistatin and its homologue FLRG (Bartholin et al 2002). Growth factors (e.g.…”
Section: Discussionsupporting
confidence: 76%
“…It has been shown that stromal fibroblasts supply many of the angiogenetic factors to the microenvironment of the healing wound and cancer (Fukumura et al, 1998). As expected from the findings of our cell proliferation assays using conditioned media, we identified upregulated secreted factors and cytokines that have been shown to promote cancer cell growth and survival including PDGF (Westermark and Heldin, 1991), TGFB2 (Derynck et al, 2001), FGF1 (Dignass et al, 1994), IGF binding proteins (Miyakoshi et al, 2001), MCP1 (Youngs et al, 1997), IL-6 (Conze et al, 2001), osteoprotegrin (Holen et al, 2002), ICAM1 (Gho et al, 2001), follistatin and its homologue FLRG (Bartholin et al 2002). Growth factors (e.g.…”
Section: Discussionsupporting
confidence: 76%
“…FGF1 is a pleiotropic growth factor known to regulate proliferation, migration, and differentiation of target cells, and it has been shown to promote intestinal epithelial cell migration. 17 A recent article has additionally shown that overexpression of FGFR correlates with liver metastasis in CRC, 18 and the splice form IIIc of FGFR3 has been suggested to have oncogenic effect on CRC cells. 19 Because both a block of FGFR and use of a neutralizing FGF1 antibody attenuated cancer cell migration in our assay, we speculate that FGF signaling might be one pathway responsible for the low clinical efficiency seen when using the FAP-inhibitor talabostat on metastatic CRC patients.…”
Section: Discussionmentioning
confidence: 99%
“…In a human gastric adenocarcinoma cell line, hepatocyte growth factor and transforming growth factor-␤ (TGF-␤) have been shown to stimulate in vitro invasion; 45 in the intestinal epithelial cell line IEC-6, fibroblast growth factor and keratinocyte growth factor stimulated cell migration in an in vitro wound model. 46 The v-erbA oncogene coding for a truncated thyroid hormone receptor has been shown to cooperate with platelet-derived growth factor to increase in vitro invasion. 47 In other cell types a role for the EGFR has also been demonstrated; for example, Hölting et al 48 showed that in a follicular thyroid cancer cell line EGF or TGF-␣ stimulated invasion over unstimulated cells (p Ͻ 0.02).…”
Section: Discussionmentioning
confidence: 99%